WAS
BIB icon

Winch Advisory Services’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Winch Advisory Services’s Portfolio BIB Stock Details BIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-400
Closed -$23K – 325
2018
Q2 		$23K Buy
+400
New +$21.8K 0.01% 142

Other funds holding BIB

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Howard Capital Management
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
Geneos Wealth Management
Geneos Wealth Management Englewood, Colorado $4.9B AUM 23.65% 1-Year Est. Return
CIC
Chase Investment Counsel Charlottesville, Virginia $474M AUM 95.11% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
Tower Research Capital (TRC)
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BA
BKS Advisors Southfield, Michigan $249M AUM 14.37% 1-Year Est. Return
BRC
Bell Rock Capital Rehoboth Beach, Delaware $81M AUM 9.85% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Winch Advisory Services's BIB Position: Q3 2018 in Review

Winch Advisory Services sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q3 2018, closing a stake of 400 shares — an estimated $23K sold.

Winch Advisory Services first reported a position in BIB in Q2 2018 and held it in 1 quarter. The position peaked at $23K in Q2 2018. 41 funds tracked by Wall St. Rank hold BIB as of Q3 2018.

  • Winch Advisory Services reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q3 2018 after selling out during the quarter.
  • Winch Advisory Services sold 400 ProShares Ultra NASDAQ Biotechnology shares in Q3 2018, an estimated $23K.
  • Winch Advisory Services first reported a position in ProShares Ultra NASDAQ Biotechnology in Q2 2018 and held it in 1 quarter.
  • Winch Advisory Services's ProShares Ultra NASDAQ Biotechnology position peaked at $23K in Q2 2018.
  • 41 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q3 2018.

Based on Winch Advisory Services's 13F filing for Q3 2018, filed 13 Nov 2018.